RE: Could Hepatitis B Reactivation Be Overlooked in Patients with Resolved HBV Infection and Receiving Immunosuppressive Treatment?

Authors

  • Pingyang Han Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University Faculty of Medicine, Shanghai, China
  • Pingyang Han Department of Nephrology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang Province, China
  • Ziqiu Wang Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University Faculty of Medicine, Shanghai, China
  • Ziqiu Wang Department of Clinical Medicine, Shanghai Jiao Tong University Faculty of Medicine, Shanghai, China
  • Zhaohui Wang Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University Faculty of Medicine, Shanghai, China

DOI:

https://doi.org/10.5152/tjg.2024.235342

Keywords:

AVES Editorial Office

Abstract

Cite this article as: Han P, Wang Z, Wang Z. RE: Could hepatitis B reactivation be overlooked in patients with resolved HBV infection and receiving immunosuppressive treatment? Turk J Gastroenterol. 2024;35(4):352-353.

Downloads

Published

2024-03-31

How to Cite

, P. H., , P. H., , Z. W., , Z. W., & , Z. W. (2024). RE: Could Hepatitis B Reactivation Be Overlooked in Patients with Resolved HBV Infection and Receiving Immunosuppressive Treatment?. Turkish Journal of Gastroenterology 1, 35(4), 15–18. https://doi.org/10.5152/tjg.2024.235342

Issue

Vol. 35 No. 4 (2024): ENT Updates

Section

Author’s Response